These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 3584483)

  • 1. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ
    J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.
    Brock JH; Licéaga J; Arthur HM; Kontoghiorghes GJ
    Am J Hematol; 1990 May; 34(1):21-5. PubMed ID: 2327400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload.
    Kontoghiorghes GJ; Barr J; Nortey P; Sheppard L
    Am J Hematol; 1993 Apr; 42(4):340-9. PubMed ID: 8493983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte iron kinetics in the rat explored with an iron chelator.
    Pippard MJ; Johnson DK; Finch CA
    Br J Haematol; 1982 Oct; 52(2):211-24. PubMed ID: 7126464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.
    Parkes JG; Randell EW; Olivieri NF; Templeton DM
    Biochim Biophys Acta; 1995 Apr; 1243(3):373-80. PubMed ID: 7727512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of in vivo iron mobilization by chelators in the ferrocene-loaded rat.
    Florence A; Ward RJ; Peters TJ; Crichton RR
    Biochem Pharmacol; 1992 Sep; 44(6):1023-7. PubMed ID: 1417929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
    Morel I; Cillard J; Lescoat G; Sergent O; Pasdeloup N; Ocaktan AZ; Abdallah MA; Brissot P; Cillard P
    Free Radic Biol Med; 1992 Nov; 13(5):499-508. PubMed ID: 1334028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose response studies using desferrioxamine and orally active chelators in a mouse model.
    Kontoghiorghes GJ
    Scand J Haematol; 1986 Jul; 37(1):63-70. PubMed ID: 3764334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chelators on iron uptake and release by the brain in the rat.
    Crowe A; Morgan EH
    Neurochem Res; 1994 Jan; 19(1):71-6. PubMed ID: 8139766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs.
    Kontoghiorghes GJ
    Toxicol Lett; 1995 Oct; 80(1-3):1-18. PubMed ID: 7482575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.
    Kontoghiorghes GJ
    Mol Pharmacol; 1986 Dec; 30(6):670-3. PubMed ID: 3785144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo iron mobilisation evaluation of hydroxypyridinones in 59Fe-ferritin-loaded rat model.
    Liu ZD; Lu SL; Hider RC
    Biochem Pharmacol; 1999 Mar; 57(5):559-66. PubMed ID: 9952320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ; Aldouri MA; Hoffbrand AV; Barr J; Wonke B; Kourouclaris T; Sheppard L
    Br Med J (Clin Res Ed); 1987 Dec; 295(6612):1509-12. PubMed ID: 3122880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells.
    Link G; Pinson A; Hershko C
    Blood; 1994 May; 83(9):2692-7. PubMed ID: 8167347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site specificity of iron removal from transferrin by alpha-ketohydroxypyridine chelators.
    Kontoghiorghes GJ; Evans RW
    FEBS Lett; 1985 Sep; 189(1):141-4. PubMed ID: 4029396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free radical and cytotoxic effects of chelators and their iron complexes in the hepatocyte.
    Mostert LJ; Van Dorst JA; Koster JF; Van Eijk HG; Kontoghiorghes GJ
    Free Radic Res Commun; 1987; 3(6):379-88. PubMed ID: 3508452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron mobilization from cultured hepatocytes: effect of desferrioxamine B.
    Octave JN; Schneider YJ; Crichton RR; Trouet A
    Biochem Pharmacol; 1983 Nov; 32(22):3413-8. PubMed ID: 6651865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells.
    Chua AC; Ingram HA; Raymond KN; Baker E
    Eur J Biochem; 2003 Apr; 270(8):1689-98. PubMed ID: 12694182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of desferrioxamine, rhodotorulic acid and cholylhydroxamic acid on transferrin and iron exchange with hepatocytes in culture.
    Baker E; Page M; Torrance J; Grady R
    Clin Physiol Biochem; 1985; 3(6):277-88. PubMed ID: 4075694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The iron chelators desferrioxamine and 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro.
    Jeremy JY; Kontoghiorghes GJ; Hoffbrand AV; Dandona P
    Biochem J; 1988 Aug; 254(1):239-44. PubMed ID: 3140797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.